SCHEMBL3752847

SCHEMBL3752847

O=Cc1cc(-c2ccc(C=O)c(Oc3ccccc3Cl)n2)cnc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
HTT P42858 1/20 0.39
LMNA P02545 2/20 0.37
ERN1 O75460 2/20 0.36
ADRB2 P07550 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
GAA P10253 1/20 0.34
MAP4K4 O95819 1/20 0.34
SLC6A2 P23975 3/20 0.33
PIK3CA P42336 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
AKT1 P31749 1/20 0.33
MTOR P42345 1/20 0.33
HTR1A P08908 1/20 0.33
MAPT P10636 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2D6 P10635 2/20 0.32
CYP2C19 P33261 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3752842 0.86 ALDH1A1 (0.40) ALDH1A1HTTLMNAERN1ADRB2
SCHEMBL8218294 0.84 LMNA (0.46) ALDH1A1HTTLMNAERN1ADRB2
SCHEMBL3752506 0.79 L3MBTL1 (0.46) ALDH1A1HTTLMNAERN1ADRB2
SCHEMBL3747547 0.77 MEN1 (0.40) ALDH1A1HTTLMNAERN1ADRB2
SCHEMBL3752590 0.77 KMO (0.38) ALDH1A1HTTLMNAERN1ADRB2
SCHEMBL3750086 0.77 KMT2A (0.44) LMNAADRB2SMN1; SMN2MAPTCYP1A2
SCHEMBL3745560 0.77 ALDH1A1 (0.43) ALDH1A1ERN1SMN1; SMN2PIK3CAMAPT
SCHEMBL3745406 0.76 KDM1A (0.42) LMNAMAPTCYP1A2CYP2C19NPSR1
SCHEMBL3753774 0.76 RORB (0.40) CYP1A2
SCHEMBL3753486 0.75 XDH (0.41) ALDH1A1MAPTCYP1A2CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF NAPRT, PNPO, FABP3 ALDH1A1 1855/4885HTT 411/4885LMNA 571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.